CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-21 | Fleming Alison B Chief Technology Officer | Shares withheld for taxes | −214 | $21.56 | $5K | 73,342 |
| 2020-01-21 | Brannelly Paul Executive Vice President & CFO | Shares withheld for taxes | −214 | $21.56 | $5K | 151,173 |
| 2020-01-14 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −1,321 | $23.87 | $32K | 35,716 |
| 2020-01-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −702 | $23.30 | $16K | 37,037 |
| 2020-01-02 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −1,091 | $20.58 | $22K | 171,686 |
| 2019-12-02 | Freund John Gordon Director | Other disposition | −574,916 | 0 | ||
| 2019-12-02 | Freund John Gordon Director | Other acquisition | +8,625 | 8,625 | ||
| 2019-11-29 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −4,678 | $21.73 | $102K | 172,777 |
| 2019-11-12 | Freund John Gordon Director | Other disposition | −575,000 | 574,916 | ||
| 2019-11-12 | Freund John Gordon Director | Other acquisition | +8,423 | 34,788 | ||
| 2019-11-08 | Hirsch David Director | Sale | −25,000 | $19.33 | $483K | 17,117 |
| 2019-11-08 | Fleming Alison B Chief Technology Officer | Option exercise | +25,000 | $5.73 | $143K | 98,556 |
| 2019-11-08 | Fleming Alison B Chief Technology Officer | Sale | −25,000 | $19.44 | $486K | 73,556 |
| 2019-11-08 | Fleming Alison B Chief Technology Officer | Option exercise · Stock Option (Right to Purchase) | −25,000 | 35,378 | ||
| 2019-11-07 | Ciaffoni Joseph President and CEO | Option exercise | +64,821 | $8.22 | $533K | 242,276 |
| 2019-11-07 | Ciaffoni Joseph President and CEO | Sale | −33,595 | $18.41 | $618K | 208,681 |
| 2019-11-07 | Ciaffoni Joseph President and CEO | Sale | −31,226 | $19.16 | $598K | 177,455 |
| 2019-11-07 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −64,821 | 129,641 | ||
| 2019-09-16 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −736 | $12.44 | $9K | 43,394 |
| 2019-08-29 | Hirsch David Director | Option exercise | +19,853 | $9.33 | $185K | 64,223 |
Page 25 of 32 · 635 trades